InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the detailed record of transactions filed by Cooney Charles Leland, 管理人员. Insider active across 1 company, notably Innovent Biologics, Inc.. Aggregated, 3 filings have been recorded. Activity tracked since 27 August 2026. The latest transaction was filed on 27 August 2026 (Sale). Regulator: HKEX. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Cooney Charles Leland is an executive at Innovent Biologics, Inc. He is involved in managing the company's operations, which focuses on developing biological drugs. Cooney Charles Leland is responsible for formulating business strategies and optimizing operations to ensure customer satisfaction and profitability. His expertise is essential for navigating a competitive market.